MSC Positive Markers CD105, CD90, CD73
Defines core properties of MSCs: differentiation (CD105), motility/homing (CD90), and anti-inflammatory action (CD73). Essential for regenerative therapy in musculoskeletal disorders, autoimmune diseases, liver cirrhosis, and chronic wounds.
Purity/Source Markers CD34, CD45, HLA-DR
Low/lack of expression confirms purity of therapeutic MSC population. Inclusion of HSCs supports hematopoiesis. Important for hematological issues and modulation of immune responses.
MSC Positive Markers CD34, CD45, HLA-DR
Low/lack of expression confirms purity of therapeutic MSC population. Inclusion of HSCs supports hematopoiesis. Important for hematological issues and modulation of immune responses.
Exosome Markers: CD9, CD63, CD81
Confirms product is rich in authentic, functional Extracellular Vesicles (EVs) which mediate paracrine signaling. Enhances therapeutic effect by carrying GFs (VEGF, IGF) to injury sites, promoting a regenerative microenvironment.